The impact of an integrated electronic immunization registry and logistics management information system (EIR-eLMIS) on vaccine availability in three regions in Tanzania: A pre-post and time-series analysis
•Digital supply chain information system linked to immunization registry, serves 6M.•Digital system includes stock notifications, dashboards and peer networks.•Overall stockout rate significantly lower with digital system vs. legacy system.•More time with digital system increases odds of vaccine ava...
Gespeichert in:
Veröffentlicht in: | Vaccine 2020-01, Vol.38 (3), p.562-569 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Digital supply chain information system linked to immunization registry, serves 6M.•Digital system includes stock notifications, dashboards and peer networks.•Overall stockout rate significantly lower with digital system vs. legacy system.•More time with digital system increases odds of vaccine availability.
Since 2016, the Government of Tanzania has been implementing TImR, an integrated Electronic Immunization registry-logistics management information system (EIR-LMIS) that includes stock notifications. The objective of this study is to estimate the impact of this intervention on vaccine availability.
Monthly stock-out data were collected from paper registers at facilities, an Excel-based system at districts, and the new system (TImR) across all 924 health facilities in Arusha, Tanga and Kilimanjaro Regions. Six months of stockout rates pre- and post-introduction, by antigen, were compared via a two-way analysis of variance (ANOVA). A mixed-effects logistic regression model with the TImR data identified predictors of vaccine availability across antigens.
Post-introduction, ANOVA models estimated that overall stock-out rates declined from a monthly average of 7.1% to 2.1% (p |
---|---|
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/j.vaccine.2019.10.059 |